Artron BioResearch Inc. was founded in Burnaby, British Columbia, Canada in 2002 by a team of talented and experienced professionals and scientists. With state-of-art R&D and manufacture facilities, Artron is well known for developing and manufacturing, on a large-scale, a great array of high quality antibodies, antigens and critical components of RDT products for direct application in lateral flow tests (LFT) (fertility hormones, tumor markers, drugs of abuse, cardiac markers, infectious diseases, genetically modified organisms, etc), as well as other applications (chemiluminescence test, ELISA and research-based immunoassays).
In addition, Artron offers the most advanced and cost-effective customized research and development services to design, develop, integrate, and validate all aspects of RDT systems.
As a world class leader in the rapid diagnostic test industry, we are dedicated to bringing innovations into the development of protein-based LFT for disease diagnosis and analyte detection.
Artron is an ISO 9001; 2011 & ISO 13485: 2008 certified company and it is committed to helping building up the best innovative clinical diagnostics tests across the world.